AnaptysBio, Inc.

ANAB·NasdaqGS
Compare
46.04+0.09 (+0.20%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours46.040.00 (0.00%)Oct 12, 4:00 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close45.95
Open46.16
Day range45.9946.78
52-week range20.1872.36
Off day high−1.58%
Off 52-week high−36.37%
Volume371.59K
Avg. volume (3M)559.97K
Market cap1.38B
EPS (TTM)-0.9600
Forward P/E9.08
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding29.90M
Short interest—
Earnings dateSep 21, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ANAB ABCL IMCR ACRS ANL QTTB
Market cap 1.38B 4.09B 1.50B 529.92M 915.74M 260.19M
P/E (TTM) — — — — — 2.8
Forward P/E 9.1 -16.6 -38.5 -4.6 -48.3 -8.6
Price/book 129.3 4.3 3.6 4.0 4.3 2.0
Dividend yield — — — — — —
1-year change +116.83% +122.84% −9.15% +88.48% +746.43% +111.14%
Today +0.20% +0.72% −1.19% −6.01% −8.96% +4.80%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ANAB news ›
Investor's Business Daily·Positive

Why This IPO Stock, An AnaptysBio Spinoff, Just Surged

Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily…

MarketBeat·Negative

AnaptysBio (NASDAQ:ANAB) Downgraded by Wall Street Zen to Hold

AnaptysBio (NASDAQ:ANAB - Get Free Report) was downgraded by research analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report released on Sunday, Wall Street Zen reports. Check Out Our Latest Stock Report on ANAB…

From articles in the 4Search news index.

In the news

4mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.